EUVIMEDEUVIMED entdecken
Crossref

Network pharmacology-based exploration of the mechanism of Wenweishu granule in treating chronic atrophic gastritis with spleen-stomach cold deficiency syndrome

Jia Zheng, Zhiyong Jiao, Xinyu Yang, Qing Ruan, Yuzhe Huang, Cheng Jin, Shuangying Gui, Zihua Xuan, Xiaoyi Jia

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Jia Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, …. Hauptthemen laut MEDLINE: Gastritis, Atrophic, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Wenweishu (WWS) is a traditional Chinese medicine compound formulated for chronic atrophic gastritis (CAG) treatment by warming the stomach and alleviating pain. However, its pharmacological mechanisms remain underexplored. AIM OF THE STUDY: This study investigated the therapeutic effects and potential mechanisms of WWS on CAG with spleen-stomach cold deficiency syndrome (SSCDS). METHODS: To achieve this, an SSCDS-CAG rat model and a human gastric mucosal epithelial cells (GES-1) cell model were established using multi-factor modeling and N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG) induction, respectively. WWS's effects on gastric injury were evaluated through pathology, inflammation, serum biomarkers, and apoptosis. Additionally, MNNG's effects on GES-1 cells were analyzed. Network pharmacology, involving protein-protein interaction networks, GO/KEGG enrichment, and molecular docking, was employed to predict WWS's potential targets and mechanisms in SSCDS-CAG. Mechanistic insights were further validated using immunohistochemistry, quantitative reverse transcription polymerase chain reaction, and western blotting. RESULTS: In vivo results showed that WWS alleviated symptoms in SSCDS-CAG rats, lowering symptom scores and improving gastric histopathology. It modulated serum biomarkers and reduced inflammation and apoptosis in both in vivo and in vitro studies. Network pharmacology results revealed 263 overlapping targets between WWS and SSCDS-CAG, associated with apoptosis, inflammation, and the PI3K/AKT pathway. Molecular docking revealed strong binding affinity between the core target and active WWS components. In SSCDS-CAG rats and GES-1 cells, WWS inhibited PI3K/AKT phosphorylation, increased PTEN expression, and regulated Bcl-2, Bax, and cleaved caspase-3 levels. CONCLUSION: WWS reduces inflammation and apoptosis in multi-factor CAG rats and MNNG-induced GES-1 cells by modulating the PTEN/PI3K/AKT signaling pathway and apoptosis-related proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastritis, AtrophicDrugs, Chinese HerbalAnimalsNetwork PharmacologyHumansRats, Sprague-DawleyRatsMaleCell LineApoptosisSpleenDisease Models, AnimalGastric MucosaMolecular Docking SimulationSignal TransductionProto-Oncogene Proteins c-aktChronic Disease

Stichwörter der Autor:innen

Chronic atrophic gastritisNetwork pharmacologyPTEN/PI3K/AKTSpleen-stomach cold deficiencyWenweishu

Substanzen

Drugs, Chinese HerbalProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, China.
  • College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Institute of Pharmaceutics, Anhui Academy of Chinese Medicine, Hefei, Anhui, 230012, China.
  • College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, China. Electronic address: jiaxy@ahtcm.edu.cn.

Zitieren

APA

Zheng, J., Jiao, Z., Yang, X., Ruan, Q., Huang, Y., Jin, C., Gui, S., Xuan, Z., & Jia, X. (2025). Network pharmacology-based exploration of the mechanism of Wenweishu granule in treating chronic atrophic gastritis with spleen-stomach cold deficiency syndrome. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119591

Vancouver

Zheng J, Jiao Z, Yang X, Ruan Q, Huang Y, Jin C, et al. Network pharmacology-based exploration of the mechanism of Wenweishu granule in treating chronic atrophic gastritis with spleen-stomach cold deficiency syndrome. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119591

BibTeX
@article{Zheng2025,
  author = {Zheng, Jia and Jiao, Zhiyong and Yang, Xinyu and Ruan, Qing and Huang, Yuzhe and Jin, Cheng and Gui, Shuangying and Xuan, Zihua and Jia, Xiaoyi},
  title = {Network pharmacology-based exploration of the mechanism of Wenweishu granule in treating chronic atrophic gastritis with spleen-stomach cold deficiency syndrome},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119591}
}
Kostenlos starten →